Cargando…
Contamination of Mesenchymal Stem-Cells with Fibroblasts Accelerates Neurodegeneration in an Experimental Model of Parkinson’s Disease
Pre-clinical studies have supported the use of mesenchymal stem cells (MSC) to treat highly prevalent neurodegenerative diseases such as Parkinson’s disease (PD) but preliminary trials have reported controversial results. In a rat model of PD induced by MPTP neurotoxin, we first observed a significa...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Humana Press Inc
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252034/ https://www.ncbi.nlm.nih.gov/pubmed/21503590 http://dx.doi.org/10.1007/s12015-011-9256-4 |
_version_ | 1782220596169408512 |
---|---|
author | Pereira, Marcia C. L. Secco, Mariane Suzuki, Daniela E. Janjoppi, Luciana Rodini, Carolina O. Torres, Layla B. Araújo, Bruno H. S. Cavalheiro, Esper A. Zatz, Mayana Okamoto, Oswaldo Keith |
author_facet | Pereira, Marcia C. L. Secco, Mariane Suzuki, Daniela E. Janjoppi, Luciana Rodini, Carolina O. Torres, Layla B. Araújo, Bruno H. S. Cavalheiro, Esper A. Zatz, Mayana Okamoto, Oswaldo Keith |
author_sort | Pereira, Marcia C. L. |
collection | PubMed |
description | Pre-clinical studies have supported the use of mesenchymal stem cells (MSC) to treat highly prevalent neurodegenerative diseases such as Parkinson’s disease (PD) but preliminary trials have reported controversial results. In a rat model of PD induced by MPTP neurotoxin, we first observed a significant bilateral preservation of dopaminergic neurons in the substantia nigra and prevention of motor deficits typically observed in PD such as hypokinesia, catalepsy, and bradykinesia, following intracerebral administration of human umbilical cord-derived MSC (UC-MSC) early after MPTP injury. However, surprisingly, administration of fibroblasts, mesenchymal cells without stem cell properties, as a xenotransplantation control was highly detrimental, causing significant neurodegeneration and motor dysfunction independently of MPTP. This observation prompted us to further investigate the consequences of transplanting a MSC preparation contaminated with fibroblasts, a plausible circumstance in cell therapy since both cell types display similar immunophenotype and can be manipulated in vitro under the same conditions. Here we show for the first time, using the same experimental model and protocol, that transplantation of UC-MSC induced potent neuroprotection in the brain resulting in clinical benefit. However, co-transplantation of UC-MSC with fibroblasts reverted therapeutic efficacy and caused opposite damaging effects, significantly exacerbating neurodegeneration and motor deficits in MPTP-exposed rats. Besides providing a rationale for testing UC-MSC transplantation in early phases of PD aiming at delaying disease progression, our pre-clinical study suggests that fibroblasts may be common cell contaminants affecting purity of MSC preparations and clinical outcome in stem cell therapy protocols, which might also explain discrepant clinical results. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s12015-011-9256-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-3252034 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Humana Press Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-32520342012-01-11 Contamination of Mesenchymal Stem-Cells with Fibroblasts Accelerates Neurodegeneration in an Experimental Model of Parkinson’s Disease Pereira, Marcia C. L. Secco, Mariane Suzuki, Daniela E. Janjoppi, Luciana Rodini, Carolina O. Torres, Layla B. Araújo, Bruno H. S. Cavalheiro, Esper A. Zatz, Mayana Okamoto, Oswaldo Keith Stem Cell Rev Article Pre-clinical studies have supported the use of mesenchymal stem cells (MSC) to treat highly prevalent neurodegenerative diseases such as Parkinson’s disease (PD) but preliminary trials have reported controversial results. In a rat model of PD induced by MPTP neurotoxin, we first observed a significant bilateral preservation of dopaminergic neurons in the substantia nigra and prevention of motor deficits typically observed in PD such as hypokinesia, catalepsy, and bradykinesia, following intracerebral administration of human umbilical cord-derived MSC (UC-MSC) early after MPTP injury. However, surprisingly, administration of fibroblasts, mesenchymal cells without stem cell properties, as a xenotransplantation control was highly detrimental, causing significant neurodegeneration and motor dysfunction independently of MPTP. This observation prompted us to further investigate the consequences of transplanting a MSC preparation contaminated with fibroblasts, a plausible circumstance in cell therapy since both cell types display similar immunophenotype and can be manipulated in vitro under the same conditions. Here we show for the first time, using the same experimental model and protocol, that transplantation of UC-MSC induced potent neuroprotection in the brain resulting in clinical benefit. However, co-transplantation of UC-MSC with fibroblasts reverted therapeutic efficacy and caused opposite damaging effects, significantly exacerbating neurodegeneration and motor deficits in MPTP-exposed rats. Besides providing a rationale for testing UC-MSC transplantation in early phases of PD aiming at delaying disease progression, our pre-clinical study suggests that fibroblasts may be common cell contaminants affecting purity of MSC preparations and clinical outcome in stem cell therapy protocols, which might also explain discrepant clinical results. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s12015-011-9256-4) contains supplementary material, which is available to authorized users. Humana Press Inc 2011-04-19 2011 /pmc/articles/PMC3252034/ /pubmed/21503590 http://dx.doi.org/10.1007/s12015-011-9256-4 Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Article Pereira, Marcia C. L. Secco, Mariane Suzuki, Daniela E. Janjoppi, Luciana Rodini, Carolina O. Torres, Layla B. Araújo, Bruno H. S. Cavalheiro, Esper A. Zatz, Mayana Okamoto, Oswaldo Keith Contamination of Mesenchymal Stem-Cells with Fibroblasts Accelerates Neurodegeneration in an Experimental Model of Parkinson’s Disease |
title | Contamination of Mesenchymal Stem-Cells with Fibroblasts Accelerates Neurodegeneration in an Experimental Model of Parkinson’s Disease |
title_full | Contamination of Mesenchymal Stem-Cells with Fibroblasts Accelerates Neurodegeneration in an Experimental Model of Parkinson’s Disease |
title_fullStr | Contamination of Mesenchymal Stem-Cells with Fibroblasts Accelerates Neurodegeneration in an Experimental Model of Parkinson’s Disease |
title_full_unstemmed | Contamination of Mesenchymal Stem-Cells with Fibroblasts Accelerates Neurodegeneration in an Experimental Model of Parkinson’s Disease |
title_short | Contamination of Mesenchymal Stem-Cells with Fibroblasts Accelerates Neurodegeneration in an Experimental Model of Parkinson’s Disease |
title_sort | contamination of mesenchymal stem-cells with fibroblasts accelerates neurodegeneration in an experimental model of parkinson’s disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252034/ https://www.ncbi.nlm.nih.gov/pubmed/21503590 http://dx.doi.org/10.1007/s12015-011-9256-4 |
work_keys_str_mv | AT pereiramarciacl contaminationofmesenchymalstemcellswithfibroblastsacceleratesneurodegenerationinanexperimentalmodelofparkinsonsdisease AT seccomariane contaminationofmesenchymalstemcellswithfibroblastsacceleratesneurodegenerationinanexperimentalmodelofparkinsonsdisease AT suzukidanielae contaminationofmesenchymalstemcellswithfibroblastsacceleratesneurodegenerationinanexperimentalmodelofparkinsonsdisease AT janjoppiluciana contaminationofmesenchymalstemcellswithfibroblastsacceleratesneurodegenerationinanexperimentalmodelofparkinsonsdisease AT rodinicarolinao contaminationofmesenchymalstemcellswithfibroblastsacceleratesneurodegenerationinanexperimentalmodelofparkinsonsdisease AT torreslaylab contaminationofmesenchymalstemcellswithfibroblastsacceleratesneurodegenerationinanexperimentalmodelofparkinsonsdisease AT araujobrunohs contaminationofmesenchymalstemcellswithfibroblastsacceleratesneurodegenerationinanexperimentalmodelofparkinsonsdisease AT cavalheiroespera contaminationofmesenchymalstemcellswithfibroblastsacceleratesneurodegenerationinanexperimentalmodelofparkinsonsdisease AT zatzmayana contaminationofmesenchymalstemcellswithfibroblastsacceleratesneurodegenerationinanexperimentalmodelofparkinsonsdisease AT okamotooswaldokeith contaminationofmesenchymalstemcellswithfibroblastsacceleratesneurodegenerationinanexperimentalmodelofparkinsonsdisease |